Projects per year
Fingerprint
Dive into the research topics where Neurochemistry Laboratory is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
-
-
Raluca Blujdea
- Neurochemistry Laboratory - Visiting Fellow
- ANS - Neurodegeneration
- ANS - Neuroinfection & -inflammation
Person: Academic
-
WE.03-2025-27 The role of oxidized macrophage migration inhibitor factor in sporadic AD
Verberk, I. (Principal investigator) & Korth, C. (Principal investigator)
01/01/2026 → 01/10/2028
Project: Research
-
-
ANS-2025-062 Roche pTau217 K3 LiHep NCHLAB
Verberk, I. (Principal investigator)
05/09/2025 → 28/02/2027
Project: Research
Research output
-
Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100B
Hoppen, M. I., Königs, M., Teunissen, C. E., Verberk, I. M. W., Twisk, J., Oosterlaan, J. & Vijverberg, E. G. B., 2026, (Accepted/In press) In: JAMA Neurology.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile6 Downloads (Pure) -
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration
Honey, M. I. J., Hok-A-Hin, Y. S., Thijssen, E. H., Cousins, K. A. Q., van der Weijden, B., in ‘t Veld, L., Stoops, E., de Boer, S. C. M., Duits, F. H., de Houwer, J. F. H., Morrema, T. H. J., Alcolea, D., Illán-Gala, I., Fortea, J., Lleó, A., Boxer, A. L., Irwin, D. J., Lee, E. B., Shaw, L. & McMillan, C. T. & 9 others, , Jun 2026, In: Nature medicine. 32, 6, p. 2083-2095 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Open Access -
APOE and genetic risk variants influence Alzheimer's disease onset in carriers of an extra copy of APP, with and without Down syndrome
Groeneveld, J., Perlaza, D., Olivé, C., Grangeon, L., Tesi, N., Nicolas, A., Jiang, C., de Rojas, I., Wallon, D., Rousseau, S., Rovira, M., de Asúa, D. R., Moldenhauer, F., Mu, R., Cassinari, K. V., Zarea, A., Escabias, J. A., Lambert, J.-C., Pijnenburg, Y. A. L. & Hulsman, M. & 13 others, , 1 Aug 2026, In: Alzheimer s & dementia. 22, 8, p. e71738 e71738.Research output: Contribution to journal › Article › Academic › peer-review
Open Access
Activities
- 2 Invited talk
-
Online seminar on the interpretation and clinical implementation of the Alzheimer's blood test.
Verberk, I. (Speaker)
8 Nov 2023Activity: Talk or presentation › Invited talk › Professional
-
Video recording for VuMedi on our project: Mastermind of the Alzheimer's blood-based biomarkers
Verberk, I. (Speaker)
Oct 2023Activity: Talk or presentation › Invited talk › Professional
Press/Media
-
Podcast over Publiek-privaat samenwerken - DEMPACT
Verberk, I., De Vos, A., Burgmans, S. & Vlug, J.
25/08/2026
1 Media contribution
Press/Media: publicengagement
-
Proteomic meta analysis paints landscape of neurological markers
04/08/2026
1 item of Media coverage
Press/Media: Press / Media
-
Microglial Proteins in CSF Point to Shifting Strategies as AD Worsens
19/03/2026
1 Media contribution
Press/Media: Press / Media
Datasets
-
Additional file 2 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644842, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644842
Dataset
-
Additional file 3 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644845, https://springernature.figshare.com/articles/dataset/Additional_file_3_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644845
Dataset
-
Additional file 2 of CSF proteins of inflammation, proteolysis and lipid transport define preclinical AD and progression to AD dementia in cognitively unimpaired individuals
Del Campo, M. (Contributor), Quesada, C. (Creator), Vermunt, L. (Creator), Peeters, C. F. W. (Creator), Hok-A-Hin, Y. S. (Creator), Trieu, C. (Creator), Braber, A. D. (Creator), Verberk, I. M. W. (Creator), Visser, P. J. (Creator), Tijms, B. M. (Creator), van der Flier, W. M. (Creator) & Teunissen, C. E. (Creator), Figshare, 2024
DOI: 10.6084/m9.figshare.27644842.v1, https://springernature.figshare.com/articles/dataset/Additional_file_2_of_CSF_proteins_of_inflammation_proteolysis_and_lipid_transport_define_preclinical_AD_and_progression_to_AD_dementia_in_cognitively_unimpaired_individuals/27644842/1
Dataset